company background image
LINC logo

Linc OM:LINC Stock Report

Last Price

SEK 69.30

Market Cap

SEK 4.0b

7D

-0.9%

1Y

-17.0%

Updated

22 May, 2025

Data

Company Financials

LINC Stock Overview

A private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. More details

LINC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Linc AB Competitors

Price History & Performance

Summary of share price highs, lows and changes for Linc
Historical stock prices
Current Share PriceSEK 69.30
52 Week HighSEK 103.40
52 Week LowSEK 59.00
Beta0.89
1 Month Change6.13%
3 Month Change-5.07%
1 Year Change-17.01%
3 Year Change15.69%
5 Year Changen/a
Change since IPO-18.47%

Recent News & Updates

Recent updates

Linc AB's (STO:LINC) Prospects Need A Boost To Lift Shares

Nov 10
Linc AB's (STO:LINC) Prospects Need A Boost To Lift Shares

Shareholder Returns

LINCSE Capital MarketsSE Market
7D-0.9%-2.0%0.4%
1Y-17.0%-7.9%-3.7%

Return vs Industry: LINC underperformed the Swedish Capital Markets industry which returned -7.9% over the past year.

Return vs Market: LINC underperformed the Swedish Market which returned -3.7% over the past year.

Price Volatility

Is LINC's price volatile compared to industry and market?
LINC volatility
LINC Average Weekly Movement6.1%
Capital Markets Industry Average Movement7.6%
Market Average Movement6.8%
10% most volatile stocks in SE Market13.7%
10% least volatile stocks in SE Market4.2%

Stable Share Price: LINC has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: LINC's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19912Karl Tobiesonlinc.se

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies.

Linc AB Fundamentals Summary

How do Linc's earnings and revenue compare to its market cap?
LINC fundamental statistics
Market capSEK 4.02b
Earnings (TTM)SEK 244.33m
Revenue (TTM)SEK 214.95m
16.4x
P/E Ratio
18.7x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LINC income statement (TTM)
RevenueSEK 214.95m
Cost of RevenueSEK 0
Gross ProfitSEK 214.95m
Other Expenses-SEK 29.38m
EarningsSEK 244.33m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)4.22
Gross Margin100.00%
Net Profit Margin113.67%
Debt/Equity Ratio0%

How did LINC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 19:49
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Linc AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.